Rafael Amado - Net Worth and Insider Trading
Rafael Amado Net Worth
The estimated net worth of Rafael Amado is at least $2 Million dollars as of 2024-11-29. Rafael Amado is the EVP of R&D and CMO of Allogene Therapeutics Inc and owns about 540,257 shares of Allogene Therapeutics Inc (ALLO) stock worth over $1 Million. Rafael Amado is the See Remarks of Zai Lab Ltd and owns about 20,417 shares of Zai Lab Ltd (ZLAB) stock worth over $574,330. Rafael Amado is also the President, R&D of Adaptimmune Therapeutics PLC and owns about 17,237 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $12,497. Details can be seen in Rafael Amado's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rafael Amado has not made any transactions after 2024-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rafael Amado
Rafael Amado Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rafael Amado owns 4 companies in total, including Allogene Therapeutics Inc (ALLO) , Adaptimmune Therapeutics PLC (ADAP) , and Zai Lab Ltd (ZLAB) among others .
Click here to see the complete history of Rafael Amado’s form 4 insider trades.
Insider Ownership Summary of Rafael Amado
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-08-02 | EVP of R&D and CMO |
| ADAP | Adaptimmune Therapeutics PLC | 2019-08-06 | Chief Medical Officer |
| ZLAB | Zai Lab Ltd | 2024-08-12 | See Remarks |
 | | 2023-04-13 | director |
Rafael Amado Latest Holdings Summary
Rafael Amado currently owns a total of 3 stocks. Among these stocks, Rafael Amado owns 540,257 shares of Allogene Therapeutics Inc (ALLO) as of August 2, 2022, with a value of $1 Million and a weighting of 69.71%. Rafael Amado owns 20,417 shares of Zai Lab Ltd (ZLAB) as of August 12, 2024, with a value of $574,330 and a weighting of 29.64%. Rafael Amado also owns 17,237 shares of Adaptimmune Therapeutics PLC (ADAP) as of August 6, 2019, with a value of $12,497 and a weighting of 0.65%.
Latest Holdings of Rafael Amado
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-08-02 | 540,257 | 2.50 | 1,350,643 |
| ZLAB | Zai Lab Ltd | 2024-08-12 | 20,417 | 28.13 | 574,330 |
| ADAP | Adaptimmune Therapeutics PLC | 2019-08-06 | 17,237 | 0.73 | 12,497 |
Holding Weightings of Rafael Amado
Rafael Amado Form 4 Trading Tracker
According to the SEC Form 4 filings, Rafael Amado has made a total of 9 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 2,000 shares on August 2, 2022, which brought Rafael Amado around $23,940.
According to the SEC Form 4 filings, Rafael Amado has made a total of 4 transactions in Zai Lab Ltd (ZLAB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Zai Lab Ltd is the sale of 3,115 shares on August 12, 2024, which brought Rafael Amado around $50,463.
According to the SEC Form 4 filings, Rafael Amado has made a total of 0 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 11,043 shares on August 6, 2019, which brought Rafael Amado around $22,749.
Insider Trading History of Rafael Amado
- 1
Rafael Amado Trading Performance
Rafael Amado Ownership Network
Rafael Amado Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Rafael Amado is the EVP of R&D and CMO of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Rafael Amado made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 11,200 shares made by Franz B Humer .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Rafael Amado Mailing Address
Above is the net worth, insider trading, and ownership report for Rafael Amado. You might contact Rafael Amado via mailing address: 210 East Grand Ave, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
